SCHEMBL476247

SCHEMBL476247

c1ccc2c3nnc(o3)c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.43
KDM4E B2RXH2 3/20 0.41
SMN1; SMN2 Q16637 4/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
ALDH1A1 P00352 5/20 0.36
HPGD P15428 3/20 0.36
CYP1A2 P05177 3/20 0.36
MAPT P10636 2/20 0.36
MAOA P21397 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
GLA P06280 1/20 0.36
CYP3A4 P08684 1/20 0.36
PGAM1 P18669 1/20 0.36
CASP1 P29466 1/20 0.36
CASP7 P55210 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
PTGS1 P23219 1/20 0.36
OPRM1 P35372 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24624525 0.70 KDM4E (0.44) KDM4ENPC1ALDH1A1MAPTCYP3A4
SCHEMBL10559125 0.70 KDM4E (0.44) KDM4ESMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL2430925 0.63 GPR3 (0.38) GPR3KDM4EALDH1A1CYP1A2MAPT
SCHEMBL31304939 0.62 ALDH1A1 (0.41) GPR3KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL11498798 0.62 GPR3 (0.50) GPR3KDM4ESMN1; SMN2NPC1RAB9A
SCHEMBL31467394 0.62 HPRT1 (0.57) GPR3KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL30977781 0.62 HPRT1 (0.57) GPR3KDM4ESMN1; SMN2ALDH1A1HPGD
Triphenylene SCHEMBL25597 0.62 HPRT1 (0.57) GPR3KDM4ESMN1; SMN2ALDH1A1HPGD
Triphenylene SCHEMBL311118 0.62 HPRT1 (0.57) GPR3KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL1006251 0.62 HPRT1 (0.57) GPR3KDM4ESMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140184371-A1 INSULATING MATERIAL CONTAINING POLY(PHENYLENE-1,3,4-OXADIAZOLE) E I DU PONT DE NEMOURS AND COMPANY (US) 2014-07-03 US claimed
US-4876077-A HEAT TREATMENNT POLYPHENYLENE OXADIAZOLE POLYBENZOTHIAZOLE, BE NZOBISTHIAZOLE, POLYBENNZOXAZOLE, POLYBENZOBISOXAZOLE, OR POLY THIAZOLE RESEARCH DEVELOPMENT CORP. OF JAPAN (JP) 1989-10-24 US claimed
US-4205038-A UNDRAWN FILAMENT STRETCHED AT LEAST SIX TIMES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-05-27 US claimed
US-4067804-A POLYOXADIAZOLE RESIN THE FURUKAWA ELECTRIC COMPANY, LIMITED (JA) 1978-01-10 US claimed
JP-55032612-A None JP disclosed
US-20240254095-A1 NMDA Receptor Antagonist and Use Thereof SYNPHATEC (SHANGHAI) BIOPHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2024-08-01 US disclosed
CN-117754943-A Felt material, cushioning material for hot press molding, and method for producing felt material 市川株式会社 2024-03-26 CN disclosed
EP-4339189-A1 NMDA RECEPTOR ANTAGONIST AND USE THEREOF Synphatec (Shanghai) Biopharmaceutical Technology Co., Ltd. (CN) 2024-03-20 EP disclosed
US-20240034028-A1 GRAPHITE ARTICLE AND METHOD OF MAKING SAME NEOGRAF SOLUTIONS, LLC 2024-02-01 US disclosed
US-11806983-B2 Graphite article and method of making same NEOGRAF SOLUTIONS, LLC (US) 2023-11-07 US disclosed
EP-3552267-B1 ELECTRIC VEHICLE HAVING AN ENERGY REGULATING SYSTEM NEOGRAF SOLUTIONS LLC (US) 2023-05-17 EP disclosed
US-20200384731-A1 A GRAPHITE ARTICLE AND METHOD OF MAKING SAME GLADSTONE CAPITAL CORPORATION 2020-12-10 US disclosed
US-4205038-A UNDRAWN FILAMENT STRETCHED AT LEAST SIX TIMES IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-05-27 US disclosed
US-4202962-A Fibers of arylene oxadiazole/arylene N-alkylhydrazide copolymer MONSANTO COMPANY (US) 1980-05-13 US disclosed
JP-S5532612-A PROCESS OF MANUFACTURING POROUS HEAT RESISTING RESIN SHEET FURUKAWA ELECTRIC CO LTD:THE 1980-03-07 JP disclosed
US-4115503-A SPINNING, COAGULATION MONSANTO COMPANY (US) 1978-09-19 US disclosed
US-4038455-A USING N-GLYCIDYL COMPOUNDS INVENTA AG FUR FORSCHUNG UND PATENTVERWERTUNG (CH) 1977-07-26 US disclosed
US-4035465-A Drawing polyoxadiazoles filaments IMPERIAL CHEMICAL INDUSTRIES LIMITED (EN) 1977-07-12 US disclosed
US-3992504-A SULFURIC ACID, AROMATIC POLY-(1,3,4-OXADIAZOLE INVENTA AG FUR FORSCHUNG UND PATENTVERWERTUNG (CH) 1976-11-16 US disclosed
JP-S05532612-A 0001-01-01 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240254095-A1 NMDA Receptor Antagonist and Use Thereof GRIN2B, GRIN1, GRIN3A GPR3 53/4885KDM4E 2445/4885SMN1; SMN2 1445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.